RhinoCare

Company Overview

Snapshot

Founded in December 2014 by Dan Shaham, RhinoCare operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the design, development, and prototype production of its RhinoTherm inhaler device.

Business overview

RhinoCare is a medical device company specializing in respiratory solutions. The company's core product is the RhinoTherm, an inhaler device designed for the relief of nasal congestion symptoms using hyperthermia technology developed at the Weizmann Institute of Science. RhinoCare serves the healthcare market, particularly patients seeking solutions for respiratory issues, operating within the Medical Devices, Medical Treatment & Therapeutics, and Drug Delivery sectors.

Company Intelligence Q&A

What is RhinoCare's primary focus?

RhinoCare is a medical device company specializing in respiratory solutions, particularly for treating sinus congestion.

Who founded RhinoCare?

RhinoCare was founded by Dan Shaham in December 2014.

What is the core technology behind RhinoCare's product?

RhinoCare's RhinoTherm device uses hyperthermia technology, developed at the Weizmann Institute of Science, to alleviate nasal congestion symptoms.

What stage is RhinoCare currently in?

RhinoCare is currently in the Pre-Funding stage, with its product in the R&D phase.

What markets does RhinoCare target?

RhinoCare targets the medical devices, medical treatment & therapeutics, and drug delivery markets within the healthcare sector.